Discover why it's important to have guidelines addressing the use of systemic nonbiologic therapies and why oral agents still play a role now and in the future treatment of psoriatic disease from one of the country's leading prescribers, dermatologist Dr. Kenneth Gordon, Professor and Chair of Dermatology at Froedtert and Medical College of Wisconsin in Milwaukee. To view disclosure information and claim credit go to https://www.eeds.com/em/1377. This program is supported by unrestricted educational grants from Celgene and Ortho Dermatologics.